Christiana Stamoulis
Director of Finance/CFO bei INCYTE CORPORATION
Vermögen: 9 Mio $ am 31.03.2024
Profil
Zurzeit ist Christiana Stamoulis Chief Financial Officer & Executive Vice President der Incyte Corp. Frau Stamoulis ist auch im Vorstand von Hologic, Inc. In ihrer früheren Laufbahn war sie President & Chief Financial Officer bei Cogent Biosciences, Inc. und Senior VP-Strategy & Business Development bei Vertex Pharmaceuticals, Inc. sowie Managing Director-Investment Banking Division bei Citigroup, Inc. und Vice President bei Goldman Sachs & Co. LLC. Frau Stamoulis erwarb einen Bachelor-Abschluss am Massachusetts Institute of Technology und einen MBA an der MIT Sloan School of Management.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
INCYTE CORPORATION
0,04% | 14.02.2024 | 89 983 ( 0,04% ) | 5 Mio $ | 31.03.2024 |
HOLOGIC, INC.
0,02% | 07.03.2024 | 45 472 ( 0,02% ) | 4 Mio $ | 31.03.2024 |
Aktive Positionen von Christiana Stamoulis
Unternehmen | Position | Beginn |
---|---|---|
HOLOGIC, INC. | Director/Board Member | 01.11.2011 |
INCYTE CORPORATION | Director of Finance/CFO | 11.02.2019 |
Ehemalige bekannte Positionen von Christiana Stamoulis
Unternehmen | Position | Ende |
---|---|---|
COGENT BIOSCIENCES, INC. | Director of Finance/CFO | 31.01.2019 |
VERTEX PHARMACEUTICALS INCORPORATED | Corporate Officer/Principal | 01.12.2013 |
CITIGROUP INC. | Corporate Officer/Principal | 01.01.2009 |
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Corporate Officer/Principal | - |
Ausbildung von Christiana Stamoulis
Massachusetts Institute of Technology | Undergraduate Degree |
MIT Sloan School of Management | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 5 |
---|---|
HOLOGIC, INC. | Health Technology |
INCYTE CORPORATION | Health Technology |
VERTEX PHARMACEUTICALS INCORPORATED | Health Technology |
CITIGROUP INC. | Finance |
COGENT BIOSCIENCES, INC. | Health Technology |
Private Unternehmen | 1 |
---|---|
Goldman Sachs & Co. LLC
Goldman Sachs & Co. LLC Financial ConglomeratesFinance Goldman Sachs & Co. LLC (GS&Co.) is a securities brokerage firm headquartered in New York City. Founded in 1927, the firm is a subsidiary of The Goldman Sachs Group, Inc. (NYSE: GS). GS&Co. provides services to help hedge funds manage risk, monitor portfolios, maintain liquidity and build their businesses. They offer clients access to global equity and derivatives markets, as well as foreign exchange, commodities, European Lefts, rates and credit across the Americas, Europe and Asia. The firm proactively monitors capital markets, searching for pockets of liquidity and news that may require changes to those strategies. Integration with the Goldman Sachs network gives clients access to the firm's sectored block trades and their insights into price discovery. Their electronic trading program provides clients with tools to manage their trades from pre-trade analytics to post-trade analysis. | Finance |